Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.01M Buy
4,805
+685
+17% +$147K ﹤0.01% 757
2026
Q1
$911K Buy
4,120
+447
+12% +$109K ﹤0.01% 766
2025
Q4
$931K Buy
+3,673
New +$922K ﹤0.01% 746
2025
Q1
$2.2M Sell
9,687
-307
-3% -$67.5K 0.01% 537
2024
Q4
$2.05M Buy
9,994
+527
+6% +$116K 0.01% 545
2024
Q3
$2.3M Sell
9,467
-115
-1% -$26.9K 0.01% 540
2024
Q2
$2.1M Sell
9,582
-87
-0.9% -$18.9K 0.01% 542
2024
Q1
$2.17M Sell
9,669
-58
-0.6% -$13.1K 0.01% 552
2023
Q4
$2.14M Sell
9,727
-437
-4% -$92.4K 0.01% 546
2023
Q3
$2.23M Sell
10,164
-646
-6% -$146K 0.01% 501
2023
Q2
$2.07M Hold
10,810
0.01% 509
2023
Q1
$2.07M Buy
10,810
+19
+0.2% +$3.67K 0.01% 510
2022
Q4
$1.99M Buy
10,791
+1,271
+13% +$223K 0.01% 522
2022
Q3
$1.58M Sell
9,520
-217
-2% -$44.2K 0.01% 548
2022
Q2
$2.01M Sell
9,737
-729
-7% -$164K 0.01% 513
2022
Q1
$2.53M Sell
10,466
-89
-0.8% -$20.6K 0.01% 516
2021
Q4
$2.57M Buy
10,555
+214
+2% +$48.9K 0.01% 526
2021
Q3
$2.11M Sell
10,341
-314
-3% -$67.2K 0.01% 538
2021
Q2
$2.2M Buy
10,655
+156
+1% +$31.4K 0.01% 523
2021
Q1
$2M Buy
10,499
+1,291
+14% +$240K 0.01% 526
2020
Q4
$1.75M Buy
9,208
+665
+8% +$124K 0.01% 539
2020
Q3
$1.5M Buy
8,543
+2,580
+43% +$413K 0.01% 538
2020
Q2
$914K Buy
5,963
+2,939
+97% +$448K 0.01% 629
2020
Q1
$460K Hold
3,024
﹤0.01% 928
2019
Q4
$460K Sell
3,024
-396
-12% -$58K ﹤0.01% 928
2019
Q3
$494K Sell
3,420
-1,388
-29% -$207K ﹤0.01% 898
2019
Q2
$715K Sell
4,808
-752
-14% -$100K ﹤0.01% 827
2019
Q1
$711K Sell
5,560
-220
-4% -$25.9K ﹤0.01% 810
2018
Q4
$617K Sell
5,780
-1,061
-16% -$118K ﹤0.01% 816
2018
Q3
$782K Sell
6,841
-406
-6% -$45.9K ﹤0.01% 798
2018
Q2
$761K Sell
7,247
-919
-11% -$92.4K ﹤0.01% 758
2018
Q1
$713K Hold
8,166
﹤0.01% 851
2017
Q4
$713K Buy
8,166
+857
+12% +$76.5K ﹤0.01% 851
2017
Q3
$645K Buy
7,309
+36
+0.5% +$3.05K ﹤0.01% 852
2017
Q2
$504K Hold
7,273
﹤0.01% 943
2017
Q1
$504K Buy
7,273
+882
+14% +$61K ﹤0.01% 943
2016
Q4
$429K Buy
6,391
+2,089
+49% +$142K ﹤0.01% 981
2016
Q3
$313K Sell
4,302
-290,870
-99% -$20.5M ﹤0.01% 1070
2016
Q2
$20.3M Sell
295,172
-107,969
-27% -$7.56M 0.12% 271
2016
Q1
$28.6M Buy
403,141
+13,861
+4% +$938K 0.19% 185
2015
Q4
$29.3M Sell
389,280
-66,954
-15% -$4.84M 0.2% 147
2015
Q3
$29.6M Sell
456,234
-34,931
-7% -$2.31M 0.22% 141
2015
Q2
$31.6M Sell
491,165
-93,132
-16% -$6.28M 0.23% 129
2015
Q1
$41.1M Buy
584,297
+5,173
+0.9% +$341K 0.3% 85
2014
Q4
$37.6M Buy
579,124
+172,052
+42% +$10.6M 0.29% 78
2014
Q3
$22M Buy
407,072
+395,302
+3,359% +$21.5M 0.19% 152
2014
Q2
$628K Sell
11,770
-40
-0.3% -$2.06K 0.01% 812
2014
Q1
$562K Sell
11,810
-10
-0.1% -$468 0.01% 840
2013
Q4
$567K Hold
11,820
0.01% 810
2013
Q3
$506K Hold
11,820
0.01% 815
2013
Q2
$506K Buy
+11,820
New +$509K 0.01% 780

Other funds holding STE

Glenmede Trust's STE Position: Q2 2026 in Review

Glenmede Trust increased its Steris (STE) stake by 17% in Q2 2026, buying an estimated $147K and bringing the position to 4,805 shares worth $1.01M. The position accounts for ﹤0.01% of the portfolio, ranked #757.

Glenmede Trust first reported a position in STE in Q2 2013 and has held it in 51 quarters since. The position peaked at $41.1M in Q1 2015. 830 funds tracked by Wall St. Rank hold STE as of Q2 2026.

  • Glenmede Trust held 4,805 shares of Steris worth $1.01M as of Q2 2026.
  • Glenmede Trust bought 685 Steris shares in Q2 2026, an estimated $147K.
  • Steris made up ﹤0.01% of Glenmede Trust's portfolio in Q2 2026, its #757 holding.
  • Glenmede Trust first reported a position in Steris in Q2 2013 and has held it in 51 quarters since.
  • Glenmede Trust's Steris position peaked at $41.1M in Q1 2015.
  • 830 funds tracked by Wall St. Rank held Steris as of Q2 2026.

Based on Glenmede Trust's 13F filing for Q2 2026, filed 10 Aug 2026.